Yoshida K, Okuda H, Hayashi Y, Nakagiri Y, Sekiba K
Department of Obstetrics and Gynecology, Okayama University Medical School.
Nihon Sanka Fujinka Gakkai Zasshi. 1991 Mar;43(3):261-5.
A total of 102 cases of adenocarcinoma of the uterine cervix were reviewed to define the clinical and pathological behavior. In the 18 years between 1970 and 1987 the incidence of cervical adenocarcinoma increased. The rate of lymph node involvement in stage Ib was 16.1% (5/31) and in stage II 26.2% (11/42). There was no difference between the rate of lymph node involvement in adenocarcinoma and squamous cell carcinoma. The 5-year survival rates were as follows: stage I 83.3% (25/30), stage II 58.1% (18/31), stage III (0/4), stage IV (2/5), and all stages 64.3% (45/70). The 5-year survival rate for patients with adenocarcinoma was poor in contrast to that for patients with squamous cell carcinoma (p less than 0.05). It was suggested that adenocarcinoma was less radiosensitive than squamous cell carcinoma.
回顾了总共102例子宫颈腺癌病例,以明确其临床和病理行为。在1970年至1987年的18年间,宫颈腺癌的发病率有所上升。Ib期淋巴结受累率为16.1%(5/31),II期为26.2%(11/42)。腺癌和鳞状细胞癌的淋巴结受累率无差异。5年生存率如下:I期83.3%(25/30),II期58.1%(18/31),III期(0/4),IV期(2/5),所有分期为64.3%(45/70)。与鳞状细胞癌患者相比,腺癌患者的5年生存率较差(p<0.05)。提示腺癌的放射敏感性低于鳞状细胞癌。